One of the leading trade associations advocating for the widespread availability of generic drugs and biosimilars has brought on a new deputy general counsel.

Rachel Sher has joined the Association for Accessible Medicines from the U.S. Food and Drug Administration, where she most recently served as senior policy analyst in the agency’s Office of Policy.